BBC
BBC
About Virtus Biotech Clinical Trials ETF
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
About Virtus Biotech Clinical Trials ETF
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 ERAS | Erasca, Inc. | 3.55% | 72.15K | $1.29M |
 ELVN | Enliven Therapeutics, Inc. | 1.90% | 15.41K | $690.96K |
 TNGX | Tango Therapeutics, Inc. | 1.84% | 27.78K | $668.39K |
 DNTH | Dianthus Therapeutics, Inc. | 1.61% | 6.17K | $585.12K |
 ORKA | Oruka Therapeutics, Inc. | 1.59% | 8.61K | $577.05K |
 ALMS | Alumis Inc. Common Stock | 1.42% | 22.61K | $517.45K |
 RZLT | Rezolute, Inc. | 1.41% | 144.31K | $512.30K |
 SYRE | Spyre Therapeutics, Inc. | 1.36% | 7.72K | $494.48K |
 KOD | Kodiak Sciences Inc. | 1.35% | 10.91K | $491.67K |
 RVMD | Revolution Medicines, Inc. | 1.33% | 3.29K | $483.66K |
 RLAY | Relay Therapeutics, Inc. | 1.31% | 32.35K | $477.12K |
 CRVS | Corvus Pharmaceuticals, Inc. | 1.30% | 31.03K | $473.27K |
 DFTX | Definium Therapeutics, Inc. | 1.25% | 20.70K | $453.91K |
 CGON | CG Oncology, Inc. Common stock | 1.18% | 6.34K | $426.82K |
 NTLA | Intellia Therapeutics, Inc. | 1.17% | 28.80K | $425.62K |
 ANAB | AnaptysBio, Inc. | 1.12% | 5.78K | $405.73K |
 TYRA | Tyra Biosciences, Inc. | 1.11% | 11.48K | $404.83K |
 TECX | Tectonic Therapeutic, Inc. | 1.08% | 13.14K | $393.66K |
 ALLO | Allogene Therapeutics, Inc. | 1.08% | 172.03K | $392.22K |
 CNTA | Centessa Pharmaceuticals plc | 1.07% | 9.80K | $387.90K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Canada
United Kingdom
Netherlands
Ireland
Switzerland
Germany
SingaporeSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Canada United Kingdom Netherlands Ireland Switzerland Germany SingaporeHoldings (Top 20)
ERAS
Erasca, Inc.
ELVN
Enliven Therapeutics, Inc.
TNGX
Tango Therapeutics, Inc.
DNTH
Dianthus Therapeutics, Inc.
ORKA
Oruka Therapeutics, Inc.
ALMS
Alumis Inc. Common Stock
RZLT
Rezolute, Inc.
SYRE
Spyre Therapeutics, Inc.
KOD
Kodiak Sciences Inc.
RVMD
Revolution Medicines, Inc.
RLAY
Relay Therapeutics, Inc.
CRVS
Corvus Pharmaceuticals, Inc.
DFTX
Definium Therapeutics, Inc.
CGON
CG Oncology, Inc. Common stock
NTLA
Intellia Therapeutics, Inc.
ANAB
AnaptysBio, Inc.
TYRA
Tyra Biosciences, Inc.
TECX
Tectonic Therapeutic, Inc.
ALLO
Allogene Therapeutics, Inc.
CNTA
Centessa Pharmaceuticals plc